Zakharia K - Search Results

1

Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.

Nakamura I, Zakharia K, Banini BA, Mikhail DS, Kim TH, Yang JD, Moser CD, Shaleh HM, Thornburgh SR, Walters I, Roberts LR. Nakamura I, et al. Among authors: zakharia k. PLoS One. 2014 Apr 7;9(4):e92273. doi: 10.1371/journal.pone.0092273. eCollection 2014. PLoS One. 2014. PMID: 24710173 Free PMC article.

2

Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling.

Nakamura I, Zakharia K, Banini BA, Mikhail DS, Kim TH, Yang JD, Moser CD, Shaleh HM, Thornburgh SR, Walters I, Roberts LR. Nakamura I, et al. Among authors: zakharia k. PLoS One. 2015 Nov 3;10(11):e0142355. doi: 10.1371/journal.pone.0142355. eCollection 2015. PLoS One. 2015. PMID: 26528545 Free PMC article. No abstract available.

3

Hepatocellular carcinoma: Epidemiology, pathogenesis and surveillance - implications for sub-Saharan Africa.

Zakharia K, Luther CA, Alsabbak H, Roberts LR. Zakharia K, et al. S Afr Med J. 2018 Aug 8;108(8b):35-40. doi: 10.7196/SAMJ.2018.v108i8b.13499. S Afr Med J. 2018. PMID: 30182911 Review.

4

Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma.

Zakharia K, Miyabe K, Wang Y, Wu D, Moser CD, Borad MJ, Roberts LR. Zakharia K, et al. Transl Oncol. 2019 Jan;12(1):143-153. doi: 10.1016/j.tranon.2018.09.005. Epub 2018 Oct 11. Transl Oncol. 2019. PMID: 30316146 Free PMC article.

5

Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27.

Ding X, Zakharia K, Moser CD, Campbell NA, Hu C, Razumilava N, Chaiteerakij R, Shaleh HM, Greipp PT, Graham RP, Zou X, Chandan VS, Roberts LR. Ding X, et al. Among authors: zakharia k. Cancers (Basel). 2022 Oct 17;14(20):5080. doi: 10.3390/cancers14205080. Cancers (Basel). 2022. PMID: 36291862 Free PMC article.

6

Toyohara T, Nakazawa T, Zakharia K, Shimizu S, Miyabe K, Harada K, Notohara K, Yamada T, Hayashi K, Naitoh I, Hayashi K, Kataoka H. Toyohara T, et al. Among authors: zakharia k. Intern Med. 2021 Mar 15;60(6):859-866. doi: 10.2169/internalmedicine.5920-20. Epub 2020 Oct 21. Intern Med. 2021. PMID: 33087673 Free PMC article.

7

Complications, symptoms, quality of life and pregnancy in cholestatic liver disease.

Zakharia K, Tabibian A, Lindor KD, Tabibian JH. Zakharia K, et al. Liver Int. 2018 Mar;38(3):399-411. doi: 10.1111/liv.13591. Epub 2017 Oct 3. Liver Int. 2018. PMID: 28921801 Review.

8

Infectious esophagitis in the immunosuppressed: Candida and beyond.

Zakharia K, Tabibian JH. Zakharia K, et al. J Community Med (Reno). 2018;1:1004. doi: 10.33582/2637-4900/1004. Epub 2018 Apr 5. J Community Med (Reno). 2018. PMID: 31897451 Free PMC article.

9

Hedgehog Signaling Modulates Interleukin-33-Dependent Extrahepatic Bile Duct Cell Proliferation in Mice.

Razumilava N, Shiota J, Mohamad Zaki NH, Ocadiz-Ruiz R, Cieslak CM, Zakharia K, Allen BL, Gores GJ, Samuelson LC, Merchant JL. Razumilava N, et al. Among authors: zakharia k. Hepatol Commun. 2018 Dec 11;3(2):277-292. doi: 10.1002/hep4.1295. eCollection 2019 Feb. Hepatol Commun. 2018. PMID: 30766964 Free PMC article.

10

Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist.

Malik A, Kardashian AA, Zakharia K, Bowlus CL, Tabibian JH. Malik A, et al. Among authors: zakharia k. Liver Res. 2019 Jun;3(2):118-127. doi: 10.1016/j.livres.2019.04.001. Epub 2019 May 27. Liver Res. 2019. PMID: 32042471 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page